Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin’s Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study - Engert, A; Diehl, V; Franklin, J (J Clin Oncol, 2009)
et al.